The Prostate's Listening Switch: Testosterone, the Androgen Receptor and the Logic of Blockade
Movember 2026 turns attention to prostate cancer, but the biology beneath the campaign begins with a molecular switch: the androgen receptor. This explainer follows testosterone from the bloodstream into prostate cells, examines how the receptor rewrites gene transcription, and considers why blocking the signal is both a powerful therapy and a problem that cancer learns to circumvent.